Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000463956 | SCV000551406 | benign | not provided | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022800 | SCV000673515 | likely benign | not specified | 2020-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ACT Genomics, |
RCV001265633 | SCV001443777 | likely benign | Breast neoplasm | 2020-11-06 | criteria provided, single submitter | clinical testing | The allele frequency of this variant c.719C>T (p.Pro240Leu) is 0.0083 in East Asian of gnomAD and 0.011 in East Asian in 1000 Genomes. For the reason, this variant has been classified as Likely Benign. |
Prevention |
RCV003970287 | SCV004788198 | benign | GALNT12-related disorder | 2020-05-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |